4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001553878-15-000001
$ALNYCIK 0001178670operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:10 PM ET
Size
9.3 KB
Accession
0001553878-15-000001
Insider Transaction Report
Form 4
Reid Laurence
SVP, Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-12-31−17,000→ 133,609 totalExercise: $15.99Exp: 2020-06-11→ Common Stock (17,000 underlying) - Exercise/Conversion
Common Stock
2014-12-31$15.99/sh+17,000$271,830→ 20,905 total - Tax Payment
Common Stock
2014-12-31$97.00/sh−2,802$271,794→ 18,103 total
Holdings
- 1,766(indirect: By Managed Account)
Common Stock
Footnotes (2)
- [F1]The reporting person owns 1,766 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- [F2]The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:10 PM ET
- Size
- 9.3 KB